The Effects of Ondansetron, a 5-HT3 Receptor Antagonist, on Progressive Supranuclear Palsy

Update Item Information
Identifier 19990315_nanos_posters_43
Title The Effects of Ondansetron, a 5-HT3 Receptor Antagonist, on Progressive Supranuclear Palsy
Creator Martin. W. ten Hove, MD; J.R. Broughton; D.P. Munoz; R. Riopelle
Affiliation Kingston, Ontario
Subject Progressive Supranuclear Palsy; PSP; Treatment; Ondansetron
Description Progressive Supranuclear Palsy (PSP) is a neurodegenerative characterized by supranuclear gaze palsy, pseudobulbar palsy, dysarthria, dystonic rigidity of the neck and trunk, and dementia. This disorder is often resistant to medical therapy including dopaminergic agents. To date, no medication has been shown to improve the oculomotor abnormalities associated with this condition.
Date 1999-03-15
Language eng
Format application/pdf
Type Text
Source 1999 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 1999: Poster Sesssion
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s65f1zpg
Setname ehsl_novel_nam
ID 184277
Reference URL https://collections.lib.utah.edu/ark:/87278/s65f1zpg
Back to Search Results